A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institutions: Harvard University, McLean Hospital, Eli Lilly (United States)
Language: English
Subfield: Clinical Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2095227090
